Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultra-sound Guided Peri-neural Platelet Rich Plasma Injection in Treatment of Chemotherapy Induced Peripheral Neuropathy
NCT05348408Phase 2Completed
- Sponsor
- South Egypt Cancer Institute
- Start
- Apr 2022
- Primary completion
- Dec 2024
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of autologous platelet-rich plasma in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by South Egypt Cancer Institute. Started Apr 2022; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT05348408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05348408.